{
 "name": "啟弘生技",
 "slug": "tw-6939",
 "aliases": [
  "啟弘生物科技股份有限公司",
  "TFBS",
  "6939"
 ],
 "ticker": "6939",
 "industry": "生技醫療業",
 "website": "https://www.tfbsbio.com/",
 "summary": "啟弘生技（6939）是興櫃的生技醫療類股公司，2016 年成立，2023 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "啟弘生物科技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "TFBS",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2023-05-15",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2016-05-10",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "阮大同",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "阮大同",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 353841610,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.tfbsbio.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：AAV病毒載體CDMO服務",
   "value": "基因治療產品委託開發製造｜已與ONODERA GT Pharma簽署合作協議｜日本合作案",
   "unit": "",
   "as_of": "2026-10-14",
   "source": "https://www.tfbsbio.com/zh-TW/new/qdvyhgXrjfa2310Z",
   "note": "公司提供的製造服務，不是公司自有候選藥；官網未公開合作藥物代號、確切適應症別或臨床期別，不移植合作方的研發階段。"
  },
  {
   "claim": "管線：生物安全性檢測服務",
   "value": "細胞治療與再生醫學相關產品開發支援｜已與TOKIWA Bio簽署服務協議｜日本合作案",
   "unit": "",
   "as_of": "2026-10-14",
   "source": "https://www.tfbsbio.com/zh-TW/new/qdvyhgXrjfa2310Z",
   "note": "屬檢測服務；Stealth RNA Vector為TOKIWA Bio平台，不列作啟弘自有管線。公告沒有逐項簽約日期，故未建立符合YYYY-MM-DD格式的授權合作fact。"
  },
  {
   "claim": "管線：多價型腸病毒疫苗抗原CDMO服務",
   "value": "第二代多價型腸病毒疫苗抗原製程開發｜已與高端疫苗擴大簽署合作合約｜台灣合作案",
   "unit": "",
   "as_of": "2026-10-14",
   "source": "https://www.tfbsbio.com/zh-TW/new/qdvyhgXrjfa2310Z",
   "note": "公司提供CDMO服務；疫苗屬高端疫苗資產，官網未披露疫苗代號與臨床期別，未當作啟弘自有藥物或授權交易。"
  }
 ],
 "provided_by": "public_sources",
 "verified_at": "2026-10-22",
 "url": "https://drugnews.com.tw/companies/tw-6939.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}